相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Access to colorectal cancer (CRC) chemotherapy and the associated costs in a South African public healthcare patient cohort
Candice-lee Herbst et al.
JOURNAL OF CANCER POLICY (2018)
Out-of-Pocket Spending and Financial Burden Among Medicare Beneficiaries With Cancer
Amol K. Narang et al.
JAMA ONCOLOGY (2017)
Real-world Direct Health Care Costs for Metastatic Colorectal Cancer Patients Treated With Cetuximab or Bevacizumab-containing Regimens in First-line or First-line Through Second-line Therapy
Stephen Johnston et al.
CLINICAL COLORECTAL CANCER (2017)
Overspending driven by oversized single dose vials of cancer drugs
Peter B. Bach et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Overspending driven by oversized single dose vials of cancer drugs
Peter B. Bach et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer
Robert J. Mayer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2014)
Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
R. Labianca et al.
ANNALS OF ONCOLOGY (2013)
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
B. Glimelius et al.
ANNALS OF ONCOLOGY (2013)
Corroboration of claims algorithm for second-line costs of metastatic colorectal cancer treatment with targeted agents
Stacey DaCosta Byfield et al.
JOURNAL OF MEDICAL ECONOMICS (2013)
Estimating the incidence of colorectal cancer in Sub–Saharan Africa: A systematic analysis
Alice Graham et al.
Journal of Global Health (2013)
Paying for and receiving benefits from health services in South Africa: is the health system equitable?
John E. Ataguba et al.
HEALTH POLICY AND PLANNING (2012)
Sex disparities in colorectal cancer incidence by anatomic subsite, race and age
Gwen Murphy et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Healthcare costs associated with bevacizumab and cetuximab in second-line treatment of metastatic colorectal cancer
Hongbo Yang et al.
JOURNAL OF MEDICAL ECONOMICS (2011)
Pharmacoeconomics: NICE's approach to decision-making
Michael Rawlins et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
The Average Body Surface Area of Adult Cancer Patients in the UK: A Multicentre Retrospective Study
Joseph J. Sacco et al.
PLOS ONE (2010)
Association of adherence to lifestyle recommendations and risk of colorectal cancer: a prospective Danish cohort study
Helene Kirkegaard et al.
BRITISH MEDICAL JOURNAL (2010)
Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first- line treatment of metastatic colorectal cancer: Updated results from the BICC-C study
Charles S. Fuchs et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Patient preference for oral or intravenous chemotherapy: A randomised cross-over trial comparing capecitabine and Nordic fluorouracil/leucovorin in patients with colorectal cancer
P. Pfeiffer et al.
EUROPEAN JOURNAL OF CANCER (2006)
Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer
T Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
XELOX (capecitabine plus oxaliplatin):: Active first-line therapy for patients with metastatic colorectal cancer
J Cassidy et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin:: a randomised crossover trial in advanced colorectal cancer
MM Borner et al.
EUROPEAN JOURNAL OF CANCER (2002)
Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: Results of a large phase III study
E Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
分享论文
